Timone University Hospital

The Unité neurovasculaire at Timone University Hospital is evaluating the impact of tranexamic acid on patients with hyperacute spontaneous intracerebral haemorrhage. The trial aims to determine whether early treatment can lower the risk of death within the first 28 days after the event.

• TXA effectiveness in hyperacute ICH
• Reducing 28‑day mortality
• Optimizing emergency care protocols

This work highlights the site’s commitment to advancing acute stroke care through targeted therapeutic strategies.

Researchers are testing an intensified regimen of temozolomide in adults newly diagnosed with glioblastoma to see if survival can be extended beyond the current standard. The study compares this approach with the established Stupp protocol and measures overall survival outcomes.

• Early temozolomide intensification
• Comparative survival outcomes
• Evaluation of the Stupp protocol

The trial reflects the department’s focus on improving therapeutic options for aggressive brain tumors.

A randomized study is assessing the benefit of azathioprine for preventing relapses in patients with myelin oligodendrocyte glycoprotein antibody‑associated disease (MOG‑AD). The goal is to establish whether long‑term immunosuppression can reduce the frequency of disease attacks after the initial episode.

• Azathioprine versus placebo
• Long‑term relapse prevention
• Double‑blind multicenter design

This investigation underscores the site’s dedication to innovative treatments for rare neurological disorders.